Colon carcinogenesis: Learning from NF-κB and AP-1

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 7, 2010, Pages 1061-1065

  Vaiopoulos, Aristides G ^a   Papachroni, Katerina K ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

AP 1; Colorectal cancer; Inflammation; NF B; Signal transduction

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY RNA; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; G PROTEIN COUPLED RECEPTOR ANTAGONIST; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; NUTRACEUTICAL; ONCOPROTEIN; PEPTIDE DERIVATIVE; PLACEBO; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 1 INHIBITOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CANCER GENE THERAPY; CANCER GENETICS; CANCER RISK; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CHRONIC INFLAMMATION; CLINICAL TRIAL; COLON CANCER; COLON CARCINOGENESIS; COLON CARCINOMA; COLON POLYP; COLORECTAL ADENOMA; COLORECTAL CANCER; DISEASE COURSE; ENTERITIS; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; NONHUMAN; PHENOTYPE; PROTEIN DEFECT; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SHORT SURVEY; SIGNAL TRANSDUCTION; SOLID TUMOR; TRANSCRIPTION REGULATION; ANIMAL; COLONIC NEOPLASMS; METABOLISM; PATHOLOGY;

ANIMALS; COLONIC NEOPLASMS; HUMANS; NF-KAPPA B; TRANSCRIPTION FACTOR AP-1;

EID: 77953544143     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.03.018     Document Type: Short Survey

References (29)

1. Ashida R., Kazunari T., Sasaki E., Watanabe T., Fujiwara Y., Oshitani N., et al. AP-1 and colorectal cancer. Inflammopharmacology 2005, 13:113-125.
2. Basseres D.S., Baldwin A.S. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 2006, 25:6817-6830.
3. Bubici C., Papa S., Pham C.G., Zazzeroni F., Franzoso G. The NF-κB mediated control of ROS and JNK signaling. Histol Histopathol 2006, 21:69-80.
4. Chen F., Castranova V. Nuclear factor-κ-B, an unappreciated tumor suppressor. Cancer Res 2007, 67:11093-11098.
5. Colell A., Coll O., Mari M., Fernández-Checa J.C., García-Ruiz C. Divergent role of ceramide generated by exogenous sphingomyelinases on NF-kappa B activation and apoptosis in human colon HT-29 cells. FEBS Lett 2002, 526:15-20.
6. Collett G.P., Campbell F.C. Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 2004, 25:2183-2189.
7. Debruyne P.R., Bruyneel E.A., Li X., Zimber A., Gespach C., Mareel M.M. The role of bile acids in carcinogenesis. Mutat Res 2001, 480-481:359-369.
8. Grau R., Punzon C., Fresno M., Iniguez A. Peroxisome-proliferator-activated receptor α agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1. Biochem J 2006, 395:81-88.
9. Hasselblatt P., Gresh L., Kudo H., Guinea-Viniegra J., Wagner E.F. The role of the transcription factor AP-1 in colitis-associated and beta-catenin-dependent intestinal tumorigenesis in mice. Oncogene 2008, 27:6102-6109.
10. Horst D., Budczies J., Brabletz T., Kirchner T., Hlubek F. Invasion associated up-regulation of nuclear factor κB target genes in colorectal cancer. Cancer 2009, 115:4946-4958.
11. Karamouzis M.V., Konstantinopoulos P.A., Pappavassiliou A.G. The activator protein-1 transcription factor in respiratory epithelium carcinogenesis. Mol Cancer Res 2007, 5:109-120.
12. Karin M. Nuclear factor-κB in cancer development and progression. Nature 2006, 441:431-436.
13. Konstantinopoulos P.A., Vandoros G.P., Karamouzis M.V., Gkermpesi M., Sotiropoulou-Bonikou G., Papavassiliou A.G. EGF-R is expressed and AP-1 and NF-κB are activated in stromal myofibroblasts surrounding colon adenocarcinomas paralleling expression of COX-2 and VEGF. Cell Oncol 2007, 29:477-482.
14. Konstantinopoulos P.A., Vandoros G.P., Sotiropoulou-Bonikou G., Kominea A., Papavassiliou A.G. NF-κB/PPARγ and/or AP-1/PPARγ on/off switches and induction of CBP in colon adenocarcinomas: correlation with COX-2. Int J Colorectal Dis 2007, 22:57-68.
15. Lauscher J.C., Gröne J., Dullat S., Hotz B., Ritz J.P., Steinhoff U., et al. Association between activation of atypical NF-kappaB1 p105 signaling pathway and nuclear beta-catenin accumulation in colorectal carcinoma. Mol Carcinog 2010, 49:121-129.
16. Maeda S., Omata M. Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Sci 2008, 99:836-842.
17. Mann B., Gelos M., Siedow A., Hanski M.L., Gratchev A., Ilyas M., et al. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal cancer. Proc Natl Acad Sci USA 1999, 96:1603-1608.
18. Markowitz S.D., Bertagnolli M.M. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009, 361:2449-2460.
19. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87:803-809.
20. Sabbah M., Emami S., Redeuilh G., Julien S., Prévost G., Zimber A., et al. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Update 2008, 11:123-151.
21. Sanchez-Munoz F., Dominguez-Lopez A., Yamamoto-Furusho J.K. Role of cytokines in inflammatory bowel disease. World J Gastroenterol 2008, 14:4280-4288.
22. Sethi G., Tergaonkar V. Potential pharmacological control of the NF-κB pathway. Trends Pharmacol Sci 2009, 30:313-321.
23. Shaulian E., Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002, 4:E131-E136.
24. Shaulian E., Karin M. AP-1 in cell proliferation and survival. Oncogene 2001, 20:2390-2400.
25. Shen H.M., Tergaonkar V. NF-κB signaling in carcinogenesis and as a potential molecular target for cancer therapy. Apoptosis 2009, 14:348-363.
26. Sinicrope F.A., Gill S. Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev 2004, 23:63-75.
27. Vandoros G.P., Konstantinopoulos P.A., Sotiropoulou-Bonikou G., Kominea A., Papachristou G.I., Karamouzis M., et al. PPAR-gamma is expressed and NF-κB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas. J Can Res Clin Oncol 2006, 132:76-84.
28. Yao K.S., Xanthoudakis S., Curran T., O'Dwyer P.J. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol 1994, 14:5997-6003.
29. Yu L.L., Yu H.G., Yu J.P., Luo H.S., Xu X.M., Li J.H. Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World J Gastroenterol 2004, 10:3255-3260.